These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7649883)

  • 1. Structure-activity relationships of pyripyropenes fungal acyl-CoA: cholesterol acyltransferase inhibitors.
    Obata R; Sunazuka T; Li Z; Tomoda H; Omura S
    J Antibiot (Tokyo); 1995 Jul; 48(7):749-50. PubMed ID: 7649883
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. II. Structure elucidation of pyripyropenes A, B, C and D.
    Kim YK; Tomoda H; Nishida H; Sunazuka T; Obata R; Omura S
    J Antibiot (Tokyo); 1994 Feb; 47(2):154-62. PubMed ID: 8150710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyripyropenes, Novel ACAT inhibitors produced by Aspergillus fumigatus. III. Structure elucidation of pyripyropenes E to L.
    Tomoda H; Tabata N; Yang DJ; Takayanagi H; Nishida H; Omura S; Kaneko T
    J Antibiot (Tokyo); 1995 Jun; 48(6):495-503. PubMed ID: 7622436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyripyropenes, highly potent inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus.
    Omura S; Tomoda H; Kim YK; Nishida H
    J Antibiot (Tokyo); 1993 Jul; 46(7):1168-9. PubMed ID: 8360113
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R.
    Tomoda H; Tabata N; Yang DJ; Namatame I; Tanaka H; Omura S; Kaneko T
    J Antibiot (Tokyo); 1996 Mar; 49(3):292-8. PubMed ID: 8626247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
    Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. I. Production, isolation, and biological properties.
    Tomoda H; Kim YK; Nishida H; Masuma R; Omura S
    J Antibiot (Tokyo); 1994 Feb; 47(2):148-53. PubMed ID: 8150709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2).
    Zhan Y; Zhang XW; Xiong Y; Li BL; Nan FJ
    Org Biomol Chem; 2016 Jan; 14(2):747-751. PubMed ID: 26584338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 2.
    Ohtawa M; Yamazaki H; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 May; 23(9):2659-62. PubMed ID: 23535327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification and structure-activity relationships of pyripyropenes. 1. Modification at the four hydroxyl groups.
    Obata R; Sunazuka T; Li Z; Tian Z; Harigaya Y; Tabata N; Tomoda H; Omura S
    J Antibiot (Tokyo); 1996 Nov; 49(11):1133-48. PubMed ID: 8982343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GERI-BP001 compounds, new inhibitors of acyl-CoA: cholesterol acyltransferase from Aspergillus fumigatus F37. I. Production, isolation, and physico-chemical and biological properties.
    Jeong TS; Kim SU; Son KH; Kwon BM; Kim YK; Choi MU; Bok SH
    J Antibiot (Tokyo); 1995 Aug; 48(8):751-6. PubMed ID: 7592016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Acyl-CoA:cholesterol acyltransferase inhibitor from Persicaria vulgaris.
    Song HY; Rho MC; Lee SW; Kwon OE; Chang YD; Lee HS; Kim YK
    Planta Med; 2002 Sep; 68(9):845-7. PubMed ID: 12357403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyripyropenes, fungal sesquiterpenes conjugated with alpha-pyrone and pyridine moieties, exhibits anti-angiogenic activity against human umbilical vein endothelial cells.
    Hayashi A; Arai M; Fujita M; Kobayashi M
    Biol Pharm Bull; 2009 Jul; 32(7):1261-5. PubMed ID: 19571395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships study of pyripyropenes: reversal of cancer cell multidrug resistance.
    Obata R; Sunazuka T; Harigaya Y; Hayashi M; Rho MC; Tomoda H; Omura S
    J Antibiot (Tokyo); 2000 Apr; 53(4):422-5. PubMed ID: 10866225
    [No Abstract]   [Full Text] [Related]  

  • 18. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of acyl-CoA: cholesterol acyltransferase by helminthosporol and its related compounds.
    Park JK; Hasumi K; Endo A
    J Antibiot (Tokyo); 1993 Aug; 46(8):1303-5. PubMed ID: 8407593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.